Thanks Pete.
Upon reading the article it seems to me that we could equally qualify for Orphan Drug Designation as well as Breakthrough Therapy.
I'd like to know if there is a reason not to pursue both avenues.
If we achieve FDA approval for Breakthrough Therapy then surely an interested party would be eager to advance a proposal to PAA
Thanks Pete.Upon reading the article it seems to me that we...
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
-0.005(2.78%) |
Mkt cap ! $69.28M | |||
| Open | High | Low | Value | Volume |
| 18.0¢ | 18.0¢ | 17.0¢ | $107.0K | 612.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 74981 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 233166 | 7 |
View Market Depth
| Last trade - 13.10pm 24/05/2024 (20 minute delay) ? |
|
|||||
|
Last
17.5¢ |
Change
-0.005 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 17.5¢ | 17.5¢ | 17.5¢ | 26492 | ||
| Last updated 14.39pm 24/05/2024 ? | |||||
| PAA (ASX) Chart |